Loading...

Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response

SIMPLE SUMMARY: Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor. Despite multimodal treatment, the prognosis of GBM patients remains very poor. Oncolytic virotherapy is being evaluated as novel treatment for this patient group and clinical trials testing oncolytic viruses...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Stavrakaki, Eftychia, Dirven, Clemens M. F., Lamfers, Martine L. M.
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913874/
https://ncbi.nlm.nih.gov/pubmed/33557101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040614
Tags: Add Tag
No Tags, Be the first to tag this record!